Pharm Analysis and QAA Validated Densitometric Method for Analysis of Atorvastatin Calcium and Metoprolol Tartarate as Bulk Drugs and In Combined Capsule Dosage Forms

Add time:09/08/2019    Source:sciencedirect.com

ABSTRACTA simple, accurate and precise high-performance thin-layer chromatographic method has been developed for the estimation of Atorvastatin Calcium and Metoprolol Tartarate simultaneously from a capsule dosage form. The method employed Silica gel 60F254s precoated plates as stationary phase and a mixture of Chloroform: Methanol: Glacial acetic acid (dil.) :: (9:1.5:0.2 ml %v/v) as mobile phase. Densitometric scanning was performed at 220 nm using Camag TLC scanner 3. The method was linear in the drug concentrations’ range of 500 to 2500 ng/spot for Atorvastatin Calcium, also for Metoprolol Tartarate with correlation coefficient of 0.984 for Atorvastatin Calcium and 0.995 for Metoprolol Tartarate respectively. The retention factor for Atorvastatin Calcium was 0.45 ± 0.04 and for Metoprolol Tartarate was 0.25 ± 0.02. The method was validated as per ICH (International Conference on Harmonisation) Guidelines, proving its utility in estimation of Atorvastatin Calcium and Metoprolol Tartarate in combined dosage form.

We also recommend Trading Suppliers and Manufacturers of (S) -1-AMino-1,2,3,4-Tetrahydronaphthalene Tartarate (cas 114352-02-2). Pls Click Website Link as below: cas 114352-02-2 suppliers

Prev:Nanocrystalline indium-based oxides by tartarate precursor route
Next:Synergistic inhibitive effect of tartarate and tungstate in preventing steel corrosion in aqueous media)